Zeenat Safdar MD MS, FACP, FCCP, ATSF
Critical Care Medicine, Pulmonology
Professor of Medicine, Houston Methodist Hospital, Weill Cornell College of Medicine
Join to view full profile
6445 Main StreetFloor 22Houston, TX 77030
Phone+1 713-441-7779
Fax+1 713-441-1949
Dr. Safdar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Director, Pulmonary Hypertension Care Center.
Director, Pulmonary Fibrosis Center Director, Houston Methodist Lung Center
Education & Training
Baylor college of medicineMS, Maters in Clinical Investigation, 2008 - 2015
New York-Presbyterian HospitalPost-Doctoral Fellowship, 2001 - 2005
Icahn School of Medicine at Mount Sinai/Morningside/WestFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2003- Icahn School of Medicine at Mount Sinai/Morningside/WestFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2001
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1995 - 1998
Certifications & Licensure
TX State Medical License 2006 - 2027
NY State Medical License 1998 - 2010
NJ State Medical License 2003 - 2005
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Baylor college of medicineMaster of Clinical Sciences
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016
- Educational Leadership Fulbright & Jaworki Award, 2012
Clinical Trials
Publications & Presentations
PubMed
- Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers.Daniel Lachant, Cristian E Botta, George Giannakoulas, Natalie Patzlaff, Scott Seaman
American Journal of Cardiovascular Drugs. 2026-09-01 - Predictive Value of the Pulmonary Artery Pulsatility Index in Pulmonary Arterial Hypertension: REVEAL Analysis.Nicole F Ruopp, Harrison W Farber, Mohammad Rahman, Navin K Kapur, Zeenat Safdar
Cardiology Research. 2026-06-01 - Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.Breanne E McCarthy, Rui Feng, Roberto Bernardo, Oksana A Shlobin, Teresa De Marco
Annals of the American Thoracic Society. 2026-05-29
Press Mentions
Deadly Vaping Illnesses Linked to THC ProductsSeptember 27th, 2019
8 Deaths, 530 Illnesses from Vaping: Here’s What to KnowSeptember 23rd, 2019
Houstonians’ Say Their Allergies Are Horrible, but Doctors Think They Know What’s to BlameOctober 15th, 2017
Grant Support
- Effect Of Spironolactone Of Collagen Synthesis In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2010–2011
Committees
- Chair, Pulmonary Hypertension Association Online University 2013 - 2015
- National Chair, PHA on the Road 2013 - 2015
- Chair, Young Council - Pulmonary vascular research institute 2013 - 2015
Professional Memberships
- Fellow
- Fellow
- Fellow
- Pulmonary Vascular Research InstituteMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
